Interleukin-18 gene-deficient mice show enhanced defense and reduced inflammation during pneumococcal meningitis

Journal of Neuroimmunology

Volumn 138, Issue 1-2, 2003, Pages 31-37

  Zwijnenburg, Petra J G ^a,b,d   Van Der Poll, Tom ^b   Florquin, Sandrine ^b   Akira, Shizuo ^c   Takeda, Kiyoshi ^c   Roord, John J ^a   Van Furth, A Marceline ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c OSAKA UNIVERSITY   (Japan)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Bacterial meningitis; IL 18; Streptococcus pneumoniae

Indexed keywords

CHEMOKINE; CYTOKINE; HYALURONIDASE; INTERLEUKIN 18;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL MENINGITIS; BRAIN TISSUE; CONTROLLED STUDY; FEMALE; GENE; INFLAMMATION; INFLAMMATORY INFILTRATE; INOCULATION; KNOCKOUT MOUSE; MALE; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; SURVIVAL; UPREGULATION;

EID: 0038297679     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00088-2     Document Type: Article

References (32)

1. Bohn E., Sing A., Zumbihl R., Bielfeldt C., Okamura H., Kurimoto M., Heesemann J., Autenrieth I.B. IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J. Immunol. 160:1998;299-307.
2. Charpentier E., Tuomanen E. Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. Microbes Infect. 2:2000;1855-1864.
3. Conti B., Park L.C., Calingasan N.Y., Kim Y., Kim H., Bae Y., Gibson G.E., Joh T.H. Cultures of astrocytes and microglia express interleukin 18. Brain Res. Mol. Brain Res. 67:1999;46-52.
4. Cunha B.A. Clinical relevance of penicillin-resistant Streptococcus pneumoniae. Semin. Respir. Infect. 17:2002;204-214.
5. Dao T., Ohashi K., Kayano T., Kurimoto M., Okamura H. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell. Immunol. 173:1996;230-235.
6. Dinarello C.A. IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J. Allergy Clin. Immunol. 103:1999;11-24.
7. Fantuzzi G., Dinarello C.A. Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J. Clin. Immunol. 19:1999;1-11.
8. Fassbender K., Mielke O., Bertsch T., Muehlhauser F., Hennerici M., Kurimoto M., Rossol S. Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases. Neurology. 53:1999;1104-1106.
9. Glimaker M., Olcen P., Anderson B. Interferon-gamma in cerebrospinal fluid from patients with viral and bacterial meningitis. Scan. J. Infect. Dis. 26:1994;141-147.
10. Grimwood K., Anderson P., Anderson V., Tan L., Nolan T. Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch. Dis. Child. 83:2000;111-116.
11. Hoban D.J., Doern G.V., Fluit A.C., Roussel-Delvallez M., Jones R.N. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32(Suppl. 2):2001;S81-S93.
12. Kohno K., Kataoka J., Ohtsuki T., Suemoto Y., Okamoto I., Usui M., Ikeda M., Kurimoto M. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J. Immunol. 158:1997;1541-1550.
13. Kornelisse R.F., Hack C.E., Savelkoul H.F., van der Pouw Kraan T.C., Hop W.C., van Mierlo G., Suur M.H., Neijens H.J., de Groot R. Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis. Infect. Immun. 65:1997;877-881.
14. Lauw F.N., Branger J., Florquin S., Speelman P., van Deventer S.J., Akira S., van der Poll T. IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J. Immunol. 168:2002;372-378.
15. Leung B.P., Culshaw S., Gracie J.A., Hunter D., Canetti C.A., Campbell C., Cunha F., Liew F.Y., McInnes I.B. A role for IL-18 in neutrophil activation. J. Immunol. 167:2001;2879-2886.
16. Mastroeni P., Clare S., Khan S., Harrison J.A., Hormaeche C.E., Okamura H., Kurimoto M., Dougan G. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect. Immun. 67:1999;478-483.
17. Meli D.N., Christen S., Leib S.L., Tauber M.G. Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae. Curr. Opin. Infect. Dis. 15:2002;253-257.
18. Nathan B.R., Scheld W.M. New advances in the pathogenesis and pathophysiology of bacterial meningitis. Curr. Infect. Dis. Rep. 2:2000;332-336.
19. Netea M.G., Kullberg B.J., Verschueren I., Van Der Meer J.W. Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta. Eur. J. Immunol. 30:2000;3057-3060.
20. Novak R., Henriques B., Charpentier E., Normark S., Tuomanen E. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature. 399:1999;590-593.
21. Ohga S., Aoki T., Okada K., Akeda H., Fujioka K., Ohshima A., Mori T., Minamishima I., Ueda K. Cerebrospinal fluid concentrations of interleukin-1 beta, tumuor necrosis factor-alpha, and interferon gamma in bacterial meningitis. Arch. Dis. Child. 70:1994;123-125.
22. Osaki T., Peron J.M., Cai Q., Okamura H., Robbins P.D., Kurimoto M., Lotze M.T., Tahara H. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. J. Immunol. 160:1998;1742-1749.
23. Puren A.J., Fantuzzi G., Gu Y., Su M.S., Dinarello C.A. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J. Clin. Invest. 101:1998;711-721.
24. Quagliarello V.J., Scheld W.M. Treatment of bacterial meningitis. N. Engl. J. Med. 336:1997;708-716.
25. Scheld W.M., Koedel U., Nathan B., Pfister H.W. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J. Infect. Dis. 186(Suppl. 2):2002;S225-S233.
26. Schuchat A., Robinson K., Wenger J.D., Harrison L.H., Farley M., Reingold A.L., Lefkowitz L., Perkins B.A. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N. Engl. J. Med. 337:1997;970-976.
27. Sugawara I., Yamada H., Kaneko H., Mizuno S., Takeda K., Akira S. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect. Immun. 67:1999;2585-2589.
28. Takeda K., Tsutsui H., Yoshimoto T., Adachi O., Yoshida N., Kishimoto T., Okamura H., Nakanishi K., Akira S. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity. 8:1998;383-390.
29. Tsutsui H., Nakanishi K., Matsui K., Higashino K., Okamura H., Miyazawa Y., Kaneda K. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 157:1996;3967-3973.
30. Wei X.Q., Leung B.P., Niedbala W., Piedrafita D., Feng G.J., Sweet M., Dobbie L., Smith A.J., Liew F.Y. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J. Immunol. 163:1999;2821-2828.
31. Zwijnenburg P.J., van der Poll T., Florquin S., van Deventer S.J., Roord J.J., van Furth A.M. Experimental pneumococcal meningitis in mice: a model of intranasal infection. J. Infect. Dis. 183:2001;1143-1146.
32. Zwijnenburg P.J., van der Poll T., Florquin S., Roord J.J., van Furth A.M. Interleukin-1 receptor type 1 gene deficient mice demonstrate an impaired host defense against pneumococcal meningitis. J. Immunol. 2003;. in press.